These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 35185925)

  • 1. High Interferon Signature Leads to Increased STAT1/3/5 Phosphorylation in PBMCs From SLE Patients by Single Cell Mass Cytometry.
    Yiu G; Rasmussen TK; Tsai BL; Diep VK; Haddon DJ; Tsoi J; Miller GD; Comin-Anduix B; Deleuran B; Crooks GM; Utz PJ
    Front Immunol; 2022; 13():833636. PubMed ID: 35185925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated STAT1 expression but not phosphorylation in lupus B cells correlates with disease activity and increased plasmablast susceptibility.
    Aue A; Szelinski F; Weißenberg SY; Wiedemann A; Rose T; Lino AC; Dörner T
    Rheumatology (Oxford); 2020 Nov; 59(11):3435-3442. PubMed ID: 32357246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Artesunate inhibits type I interferon-induced production of macrophage migration inhibitory factor in patients with systemic lupus erythematosus.
    Feng X; Chen W; Xiao L; Gu F; Huang J; Tsao BP; Sun L
    Lupus; 2017 Jan; 26(1):62-72. PubMed ID: 27230555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of Cyclin-Dependent Kinase 1 as a Novel Regulator of Type I Interferon Signaling in Systemic Lupus Erythematosus.
    Wu L; Qin Y; Xia S; Dai M; Han X; Wu Y; Zhang X; Ma J; Wang Y; Tang Y; Liu Z; Zhu W; Jallal B; Yao Y; Qu B; Shen N
    Arthritis Rheumatol; 2016 May; 68(5):1222-32. PubMed ID: 26663909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of the interferon-gamma signaling pathway in systemic lupus erythematosus peripheral blood mononuclear cells.
    Karonitsch T; Feierl E; Steiner CW; Dalwigk K; Korb A; Binder N; Rapp A; Steiner G; Scheinecker C; Smolen J; Aringer M
    Arthritis Rheum; 2009 May; 60(5):1463-71. PubMed ID: 19404947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The
    Hagberg N; Joelsson M; Leonard D; Reid S; Eloranta ML; Mo J; Nilsson MK; Syvänen AC; Bryceson YT; Rönnblom L
    Ann Rheum Dis; 2018 Jul; 77(7):1070-1077. PubMed ID: 29475858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TBK1: A key regulator and potential treatment target for interferon positive Sjögren's syndrome, systemic lupus erythematosus and systemic sclerosis.
    Bodewes ILA; Huijser E; van Helden-Meeuwsen CG; Tas L; Huizinga R; Dalm VASH; van Hagen PM; Groot N; Kamphuis S; van Daele PLA; Versnel MA
    J Autoimmun; 2018 Jul; 91():97-102. PubMed ID: 29673738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multidimensional single cell based STAT phosphorylation profiling identifies a novel biosignature for evaluation of systemic lupus erythematosus activity.
    Huang X; Guo Y; Bao C; Shen N
    PLoS One; 2011; 6(7):e21671. PubMed ID: 21799742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential Responsiveness of Monocyte and Macrophage Subsets to Interferon.
    Han S; Zhuang H; Lee PY; Li M; Yang L; Nigrovic PA; Reeves WH
    Arthritis Rheumatol; 2020 Jan; 72(1):100-113. PubMed ID: 31390156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. STAT3 phosphorylation mediates the stimulatory effects of interferon alpha on B cell differentiation and activation in SLE.
    De Groof A; Ducreux J; Aleva F; Long AJ; Ferster A; van der Ven A; van de Veerdonk F; Houssiau FA; Lauwerys BR
    Rheumatology (Oxford); 2020 Mar; 59(3):668-677. PubMed ID: 31504941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PTPN22 Variant R620W Is Associated With Reduced Toll-like Receptor 7-Induced Type I Interferon in Systemic Lupus Erythematosus.
    Wang Y; Ewart D; Crabtree JN; Yamamoto A; Baechler EC; Fazeli P; Peterson EJ
    Arthritis Rheumatol; 2015 Sep; 67(9):2403-14. PubMed ID: 26018863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoantibody-Positive Healthy Individuals Display Unique Immune Profiles That May Regulate Autoimmunity.
    Slight-Webb S; Lu R; Ritterhouse LL; Munroe ME; Maecker HT; Fathman CG; Utz PJ; Merrill JT; Guthridge JM; James JA
    Arthritis Rheumatol; 2016 Oct; 68(10):2492-502. PubMed ID: 27059145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-10 receptor expression and signalling were down-regulated in CD4⁺ T cells of lupus nephritis patients.
    Cui HD; Qi ZM; Yang LL; Qi L; Zhang N; Zhang XL; Du SY; Jiang Y
    Clin Exp Immunol; 2011 Aug; 165(2):163-71. PubMed ID: 21635228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Raf Kinase Inhibitor Sorafenib Inhibits JAK-STAT Signal Transduction in Human Immune Cells.
    Martin del Campo SE; Levine KM; Mundy-Bosse BL; Grignol VP; Fairchild ET; Campbell AR; Trikha P; Mace TA; Paul BK; Jaime-Ramirez AC; Markowitz J; Kondadasula SV; Guenterberg KD; McClory S; Karpa VI; Pan X; Olencki TE; Monk JP; Mortazavi A; Tridandapani S; Lesinski GB; Byrd JC; Caligiuri MA; Shah MH; Carson WE
    J Immunol; 2015 Sep; 195(5):1995-2005. PubMed ID: 26238487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of microRNA-155 increases IL-21 mediated STAT3 signaling and IL-21 production in systemic lupus erythematosus.
    Rasmussen TK; Andersen T; Bak RO; Yiu G; Sørensen CM; Stengaard-Pedersen K; Mikkelsen JG; Utz PJ; Holm CK; Deleuran B
    Arthritis Res Ther; 2015 Jun; 17(1):154. PubMed ID: 26055806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional assay of type I interferon in systemic lupus erythematosus plasma and association with anti-RNA binding protein autoantibodies.
    Hua J; Kirou K; Lee C; Crow MK
    Arthritis Rheum; 2006 Jun; 54(6):1906-16. PubMed ID: 16736505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. B Cell Tetherin: A Flow Cytometric Cell-Specific Assay for Response to Type I Interferon Predicts Clinical Features and Flares in Systemic Lupus Erythematosus.
    El-Sherbiny YM; Md Yusof MY; Psarras A; Hensor EMA; Kabba KZ; Dutton K; Mohamed AAA; Elewaut D; McGonagle D; Tooze R; Doody G; Wittmann M; Emery P; Vital EM
    Arthritis Rheumatol; 2020 May; 72(5):769-779. PubMed ID: 31804007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abnormalities of the type I interferon signaling pathway in lupus autoimmunity.
    Gallucci S; Meka S; Gamero AM
    Cytokine; 2021 Oct; 146():155633. PubMed ID: 34340046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of the markers BDCA-2 and BDCA-4 and production of interferon-alpha by plasmacytoid dendritic cells in systemic lupus erythematosus.
    Blomberg S; Eloranta ML; Magnusson M; Alm GV; Rönnblom L
    Arthritis Rheum; 2003 Sep; 48(9):2524-32. PubMed ID: 13130472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of Th17-Associated Interstitial Kidney Inflammation in Lupus-Prone Mice Lacking the Gene Encoding STAT-1.
    Yiu G; Rasmussen TK; Ajami B; Haddon DJ; Chu AD; Tangsombatvisit S; Haynes WA; Diep V; Steinman L; Faix J; Utz PJ
    Arthritis Rheumatol; 2016 May; 68(5):1233-44. PubMed ID: 26636548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.